These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8867855)

  • 21. [Cytotoxic activity of the leukocytes of chronic Chagas' disease patients against Trypanosoma cruzi].
    Olabuenaga SE; Rimoldi MT; Cardoni RL; Riera NE; Sánchez RA; Chiale P; de Bracco MM
    Medicina (B Aires); 1983; 43(2):168-74. PubMed ID: 6420643
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A.
    Kierszenbaum F; Gottlieb CA; Budzko DB
    Tropenmed Parasitol; 1983 Mar; 34(1):4-6. PubMed ID: 6405514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune system recognition of Trypanosoma cruzi.
    Tarleton RL
    Curr Opin Immunol; 2007 Aug; 19(4):430-4. PubMed ID: 17651955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the cellular immune response in Chagas' disease patients.
    Castes M; Araujo Z; Mosca W
    Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894
    [No Abstract]   [Full Text] [Related]  

  • 26. The importance of aberrant T-cell responses in Chagas disease.
    DosReis GA; Freire-de-Lima CG; Nunes MP; Lopes MF
    Trends Parasitol; 2005 May; 21(5):237-43. PubMed ID: 15837613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic.
    Millar AE; Wleklinski-Lee M; Kahn SJ
    J Immunol; 1999 May; 162(10):6092-9. PubMed ID: 10229851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
    Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi antigens down-regulate T lymphocyte proliferation by muscarinic cholinergic receptor-dependent release of PGE2.
    Gorelik G; Cremaschi G; Borda E; Sterin-Borda L
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(3):115-23. PubMed ID: 9777034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of immunosuppression generated by Trypanosoma cruzi of the development of Hymenolepis diminuta in CFW mice.
    Machnicka B; Choromański L
    Bull Acad Pol Sci Biol; 1980; 27(9):739-48. PubMed ID: 6778591
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi.
    Tadokoro CE; Vallochi AL; Rios LS; Martins GA; Schlesinger D; Mosca T; Kuchroo VK; Rizzo LV; Abrahamsohn IA
    J Autoimmun; 2004 Sep; 23(2):103-15. PubMed ID: 15324929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis as a cause of T-cell unresponsiveness in experimental Chagas' disease.
    Lopes MF; DosReis GA
    Braz J Med Biol Res; 1995 Aug; 28(8):913-8. PubMed ID: 8555995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trypanosoma cruzi-induced suppressor substance. I. cellular involvement and partial characterization.
    Cunningham DS; Kuhn RE
    J Immunol; 1980 May; 124(5):2122-9. PubMed ID: 6444968
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppression in mice infected with Trypanosoma cruzi (Chagas, 1909). I--Evidences of polyclonal B cell activation in experimental infections mimicked by an extract prepared from circulating trypomastigotes.
    Corsini AC; Costa MG
    Rev Inst Med Trop Sao Paulo; 1981; 23(3):114-21. PubMed ID: 6792688
    [No Abstract]   [Full Text] [Related]  

  • 36. Partial characterization of a Trypanosoma cruzi-released decomplementing factor.
    Cunningham DS; Brewer TE; Kuhn RE; Craig WH
    J Parasitol; 1981 Aug; 67(4):475-80. PubMed ID: 6790694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunology of Chagas' disease I. Circulating antigens in mice experimentally infected with Trypanosoma cruzi.
    Araujo FG
    Rev Inst Med Trop Sao Paulo; 1976; 18(6):433-9. PubMed ID: 828294
    [No Abstract]   [Full Text] [Related]  

  • 38. Protection of congenitally athymic mice against Trypanosoma cruzi infection by passive antibody transfer.
    Kierszenbaum F
    J Parasitol; 1980 Aug; 66(4):673-5. PubMed ID: 6775071
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoimmunity in Chagas' disease: immunomodulation of autoimmune and T. cruzi-specific immune responses.
    Rizzo LV; Cunha-Neto E; Teixeira AR
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():360-2. PubMed ID: 3150998
    [No Abstract]   [Full Text] [Related]  

  • 40. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?
    Kierszenbaum F; Mejia Lopez H; Sztein MB
    Immunology; 1993 Nov; 80(3):445-50. PubMed ID: 8288318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.